Global Burden of Disease of Multiple Myeloma in China from 1990 to 2021

Maigeng Zhou(National Center for Chronic and Noncommunicable Disease Control and Prevention), Jin Lu(Peking University), Kai‐Yan Liu(South China Agricultural University), Jinlei Qi(National Center for Chronic and Noncommunicable Disease Control and Prevention), Xuelin Dou(Peking University)
Blood
November 5, 2024
10.1182/blood-2024-205159
Cited by 0

Related Papers

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|6.5k
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|1.5k
Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2021|899